There is a small percentage of adults with IBD at risk of primary EBV infection. The risks of seroconversion and its complications remain through adulthood. Our results suggest that, when considering the use of thiopurines in IBD, the information on EBV serological status should be taken into account at any age.
The early life gut microbiota has been reported to be involved in neonatal weight gain and later infant growth. Therefore, this early microbiota may constitute a target for the promotion of healthy neonatal growth and development with potential consequences for later life. Unfortunately, we are still far from understanding the association between neonatal microbiota and weight gain and growth. In this context, we evaluated the relationship between early microbiota and weight in a cohort of full-term infants. The absolute levels of specific fecal microorganisms were determined in 88 vaginally delivered and 36 C-section-delivered full-term newborns at 1 month of age and their growth up to 12 months of age. We observed statistically significant associations between the levels of some early life gut microbes and infant weight gain during the first year of life. Classifying the infants into tertiles according to their Staphylococcus levels at 1 month of age allowed us to observe a significantly lower weight at 12 months of life in the C-section-delivered infants from the highest tertile. Univariate and multivariate models pointed out associations between the levels of some fecal microorganisms at 1 month of age and weight gain at 6 and 12 months. Interestingly, these associations were different in vaginally and C-section-delivered babies. A significant direct association between Staphylococcus and weight gain at 1 month of life was observed in vaginally delivered babies, whereas in C-section-delivered infants, lower Bacteroides levels at 1 month were associated with higher later weight gain (at 6 and 12 months). Our results indicate an association between the gut microbiota and weight gain in early life and highlight potential microbial predictors for later weight gain.
The Receiver Operating Characteristic (ROC) curve is a graphical tool commonly used to assess the discriminatory ability of continuous markers in binary classification problems. Different extensions of the ROC curve have been proposed in the prognosis context, where the characteristics in study are time-dependent events. Perhaps the most direct generalization is the so-called cumulative/dynamic (C/D) ROC curve. The main particularity when dealing with the C/D ROC curve estimation is the presence of incomplete information. Several approximation methods addressing this censoring problem have been suggested in the statistical literature, most of them focused on the right-censored case. Interval censorship arises naturally from those studies where subjects undergo periodical follow-ups. They may miss a scheduled appointment and the exact event times are only known to fall in a certain range. A new approach for estimating the C/D ROC curve under the particular scheme of interval censorship is presented in this work. Its finite-sample behavior is studied via Monte Carlo simulations on two different scenarios. Results suggest that the proposed approximation is better than the existing one in terms of absolute error. Its direct application is illustrated in the real-world data set which motivated this research. The uniform strong consistency and a suitable R function for its practical implementation are provided as appendices.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.